INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Corporate insider
NN

Naclerio Nicholas

DirectorCIK 0001534166

EDGAR filingsOpen in network
Disclosed transactions15
Buys / sells1 / 0
Max Insider Score50
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
5.04M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Alamar Biosciences, Inc.Director · Apr 20, 2026
8
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C
—
Apr 20, 2026
Apr 20, 2026
traded Apr 20, 2026
+0d
SEC FORM 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Grant or award
A—
5,686 sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
4.59M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

17
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
922.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

12
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
5.51M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

13
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
346.0K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
271.8K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

50
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Open-market purchase
BUY$4.00M
235.3K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Grant or award
A—
25.6K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
3.19M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
2.86M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
2.09M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

8
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

12
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
5.51M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence